EUVIMEDEUVIMED entdecken
Crossref

Comprehensive genomic profiling of Japanese patients with thoracic malignancies: A single-center retrospective study

Tetsu Hirakawa, Mihoko Doi, Kosuke Hamai, Ryo Katsura, Shinya Miyake, Suguru Fujita, Sayaka Ueno, Ken Masuda, Takuya Tanimoto, Takashi Nishisaka, Takao Hinoi, Akira Hirasawa und 1 weitere

Respiratory Investigation · 2023-11 · 61 (6) · 746-754

DOI: 10.1016/j.resinv.2023.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Investigation, 2023-11. Verfasst von Tetsu Hirakawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Hiroshima Prefectural Hospital, 1-5-54 Ujina-kanda, Minami-ku, Hiroshima, Hiroshima, 7348530, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Thoracic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Few studies have been conducted on comprehensive genomic profiling (CGP) panels in Japanese patients with thoracic malignancies after completing standard treatment. Consequently, its value in clinical practice remains unclear. METHODS: We conducted a retrospective study of Japanese patients with thoracic malignancies who underwent CGP between June 2019 and November 2022 at our hospital. We evaluated the detection rate of actionable genetic alterations and percentage of patients who received genomically-matched therapy. Furthermore, we examined the value of the CGP panel in patients who underwent multiplex gene-panel testing prior to their initial treatment. This study was performed in accordance with the principles of the Declaration of Helsinki. RESULTS: The study included 56 patients, of whom 47 (83.9%) had actionable genetic alterations and 8 (14.3%) received genomically-matched therapy. Of these, four patients were treated with approved drugs and three patients were treated with investigational agents. In addition, one patient was treated with approved drugs using the patient-directed care system. Of the 17 patients who had multiplex gene-panel testing performed at the start of their initial therapy, two (11.8%) were newly identified by the CGP panel and subsequently received genomically-matched therapy. EGFR L718Q and MET amplification were observed in two of the seven patients with epidermal growth factor receptor-tyrosine kinase inhibitor resistance. CONCLUSIONS: The CGP panel could identify genetic alterations, thereby facilitating genomically-matched therapy, even in patients with thoracic malignancies who could not be identified using multiplex gene-panel testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsThoracic NeoplasmsHumansRetrospective StudiesEast Asian PeopleGenomics

Stichwörter der Autor:innen

Comprehensive genomic profiling panelFoundationOne® CDxLung cancerNext-generation sequencing

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Hiroshima Prefectural Hospital, 1-5-54 Ujina-kanda, Minami-ku, Hiroshima, Hiroshima, 7348530, Japan.
  • Department of Genomic Medicine, Hiroshima Prefectural Hospital, 1-5-54 Ujina-kanda, Minami-ku, Hiroshima, Hiroshima, 7348530, Japan.
  • Department of Respiratory Medicine, Onomichi General Hospital, 1-10-23 Hirahara, Onomichi, Hiroshima, 7220018, Japan.
  • Department of Pathology and Laboratory Medicine, Hiroshima Prefectural Hospital, 1-5-54 Ujina-kanda, Minami-ku, Hiroshima, Hiroshima, 7348530, Japan.
  • Department of Clinical and Molecular Genetics, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-Ku, Hiroshima, Hiroshima, 7348551, Japan.
  • Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, 7008558, Japan.

Zitieren

APA

Hirakawa, T., Doi, M., Hamai, K., Katsura, R., Miyake, S., Fujita, S., Ueno, S., Masuda, K., Tanimoto, T., Nishisaka, T., Hinoi, T., Hirasawa, A., & Ishikawa, N. (2023). Comprehensive genomic profiling of Japanese patients with thoracic malignancies: A single-center retrospective study. Respiratory Investigation, 61(6), 746-754. https://doi.org/10.1016/j.resinv.2023.08.005

Vancouver

Hirakawa T, Doi M, Hamai K, Katsura R, Miyake S, Fujita S, et al. Comprehensive genomic profiling of Japanese patients with thoracic malignancies: A single-center retrospective study. Respiratory Investigation. 2023;61(6):746-754. doi:10.1016/j.resinv.2023.08.005

BibTeX
@article{Hirakawa2023,
  author = {Hirakawa, Tetsu and Doi, Mihoko and Hamai, Kosuke and Katsura, Ryo and Miyake, Shinya and Fujita, Suguru and Ueno, Sayaka and Masuda, Ken and Tanimoto, Takuya and Nishisaka, Takashi and Hinoi, Takao and Hirasawa, Akira and Ishikawa, Nobuhisa},
  title = {Comprehensive genomic profiling of Japanese patients with thoracic malignancies: A single-center retrospective study},
  journal = {Respiratory Investigation},
  year = {2023},
  volume = {61},
  number = {6},
  pages = {746--754},
  doi = {10.1016/j.resinv.2023.08.005}
}
Kostenlos starten →